SCHEMBL2032344

SCHEMBL2032344

OCCNCCCNCCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.47
CA6 P23280 3/20 0.47
CA7 P43166 3/20 0.47
CA9 Q16790 3/20 0.47
CA14 Q9ULX7 3/20 0.47
CA5B Q9Y2D0 3/20 0.47
CA2 P00918 2/20 0.47
CA4 P22748 2/20 0.47
CA5A P35218 2/20 0.47
CA3 P07451 1/20 0.47
CYP2C19 P33261 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
GLA P06280 1/20 0.44
CYP1A2 P05177 3/20 0.42
NSD2 O96028 1/20 0.39
FGB P02675 1/20 0.39
MMP14 P50281 1/20 0.39
TP53 P04637 3/20 0.39
ALOX15 P16050 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1248348 0.96 CYP2C19 (0.47) CA12CA6CA7CA9CA14
Bromide SCHEMBL30669878 0.96 CA12 (0.44) CA12CA6CA7CA9CA14
SCHEMBL8109893 0.92 ALDH1A1 (0.44) CA12CA6CA7CA9CA14
Diethanolamine SCHEMBL2256873 0.92
SCHEMBL10961785 0.89 ALOX15 (0.47) CA12CA6CA7CA9CA14
SCHEMBL9812850 0.89 ALOX15 (0.47) CA12CA6CA7CA9CA14
SCHEMBL337654 0.89
Diethanolamine SCHEMBL1571734 0.89 CA2 (0.38) CA12CA6CA7CA9CA14
SCHEMBL1001821 0.89 ALOX15 (0.47) CA12CA6CA7CA9CA14
Diethanolamine SCHEMBL23363665 0.88 TSHR (0.36) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637439-B2 Preparation of cannabichromene and related cannabinoids BAYMEDICA, INC. (US) 2026-05-26 US claimed
CN-118345204-B Amphoteric ion type environment-friendly organic chromium-free tanning agent and preparation method thereof 齐鲁工业大学(山东省科学院) 2026-02-27 CN claimed
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS BAYMEDICA, INC. 2023-03-02 US claimed
CN-111808036-B Crude oil desulfurization compound, preparation method thereof and desulfurizing agent containing crude oil desulfurization compound 中国石油化工股份有限公司 2023-01-31 CN claimed
US-8911775-B2 pH-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE (KR) 2014-12-16 US claimed
EP-2340811-B1 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same UNIV SUNGKYUNKWAN FOUND (KR) 2014-10-15 EP claimed
EP-2340811-A1 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same Sungkyunkwan University Foundation for Corporate Collaboration (KR) 2011-07-06 EP claimed
US-20110150978-A1 PH-SENSITIVE BLOCK COPOLYMER FORMING POLYIONIC COMPLEX MICELLES AND DRUG OR PROTEIN CARRIER USING THE SAME SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) 2011-06-23 US claimed
EP-0512423-B1 Aqueous solutions of cationic polyamidoamine resins HOECHST AG (DE) 1998-07-22 EP claimed
US-12637439-B2 Preparation of cannabichromene and related cannabinoids BAYMEDICA, INC. (US) 2026-05-26 US disclosed
CN-118345204-B Amphoteric ion type environment-friendly organic chromium-free tanning agent and preparation method thereof 齐鲁工业大学(山东省科学院) 2026-02-27 CN disclosed
CN-117105878-B Preparation method of pleshafu key intermediate 山东新时代药业有限公司 2025-11-21 CN disclosed
US-20250353809-A1 NITROGEN-CONTAINING CHAIN COMPOUND, PREPARATION METHOD, COMPOSITION CONTAINING SAID COMPOUND, AND USE THEREOF SHANGHAI RNACURE BIOPHARMA CO LTD (CN) 2025-11-20 US disclosed
EP-4626858-A1 NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES COMPRISING THE SAME University of Cincinnati (US) 2025-10-08 EP disclosed
EP-0031899-B1 SELF-CROSSLINKING WATER-SOLUBLE REACTION PRODUCTS, PROCESS FOR PRODUCING BINDING AGENTS FROM SUCH PRODUCTS, AND USE OF THE PRODUCTS TO INCREASE THE WET STRENGTH OF PAPER HOECHST AKTIENGESELLSCHAFT (DE) 1984-06-06 EP disclosed
EP-0031899-A1 Self-crosslinking water-soluble reaction products, process for producing binding agents from such products, and use of the products to increase the wet strength of paper HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-15 EP disclosed
US-4252604-A OPTICAL BRIGHTENERS SANDOZ LTD. (CH) 1981-02-24 US disclosed
US-4248994-A QUICK-CURING PROPERTY FABRIDYNE, INC. (US) 1981-02-03 US disclosed
US-4077920-A Flame- and smoke-resistant polyurethane foam and a method for producing said foam BRIDGESTONE TIRE COMPANY LIMITED (JA) 1978-03-07 US disclosed
US-4062736-A ARSENIC COMPOUND, POLYAMINE, REDUCING AGENT OXY METAL INDUSTRIES CORPORATION (US) 1977-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637439-B2 Preparation of cannabichromene and related cannabinoids CNR2, CNR1, OPRM1 CA12 1754/4885CA6 2426/4885CA7 2388/4885
US-20250353809-A1 NITROGEN-CONTAINING CHAIN COMPOUND, PREPARATION METHOD, COMPOSITION CONTAINING SAID COMPOUND, AND USE THEREOF NPC1, RNMT, SLC29A1 CA12 3637/4885CA6 2635/4885CA7 2440/4885
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS CNR2, CNR1, SQLE CA12 3399/4885CA6 2895/4885CA7 2243/4885
US-20110150978-A1 PH-SENSITIVE BLOCK COPOLYMER FORMING POLYIONIC COMPLEX MICELLES AND DRUG OR PROTEIN CARRIER USING THE SAME CHMP4B, PEBP1, ABCC1 CA12 575/4885CA6 658/4885CA7 1062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.